OSSIUM HEALTH, INC.
SAN FRANCISCO, California
Total Received
$39.8M
Total Awards
7
State
California
Last Updated
Mar 3, 2026
Yearly Funding Trend
$39.8M24
Top 7 Awards to OSSIUM HEALTH, INC.
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 3, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
CONT_AWD_75A50124C00032_7505_-NONE-_-NONE- BONE MARROW CRYO-BANKING TO TREAT ACUTE RADIATION SYNDROME IN A MASS-CASUALTY EMERGENCY | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SAN FRANCISCO, CA-11 | 2024 | $33,437,385 |
ASST_NON_U01AI138334_075 OSSIOSTEM-MATCHED MULTIPOTENT MSC (M3): BANKED, LOW PASSAGE BONE MARROW MSC FOR TREATMENT OF HEMATOPOIETIC ACUTE RADIATION SYNDROME. - ABSTRACT THE HEMATOPOIETIC SUBSYNDROME OF AC… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | INDIANAPOLIS, IN-07 | 2024 | $2,849,152 |
ASST_NON_R44HL142418_075 NOVEL STRATEGIES FOR STORAGE AND RECOVERY OF CADAVERIC BONE MARROW STEM CELLS - ABSTRACT BONE MARROW REPRESENTS A RICH SOURCE OF DIVERSE STEM, PROGENITOR AND OTHER CELLS OF CLINIC… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | INDIANAPOLIS, IN-07 | 2024 | $1,465,963 |
ASST_NON_R44AI183961_075 DEVELOPING A BANK OF PURIFIED MYELOID PROGENITOR CELLS AS A BRIDGING THERAPY FOR TRANSIENT PANCYTOPENIA RESULTING FROM RADIATION INJURY - ABSTRACT EXPOSURE TO EVEN MODERATE LEVELS… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | IN-90 | 2024 | $1,375,113 |
ASST_NON_R43AI155196_075 A NOVEL AND CLINICALLY FEASIBLE CO-THERAPY OF DECEASED DONOR BONE MARROW COMBINED WITH DONOR-MATCHED MESENCHYMAL STEM CELLS TO ESTABLISH IMMUNE TOLERANCE - ABSTRACT INDUCTION OF I… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | INDIANAPOLIS, IN-07 | 2024 | $299,950 |
ASST_NON_R41HL155004_075 A NOVEL APPROACH TO MESENCHYMAL STEM CELL TRANSDUCTION - PROJECT SUMMARY MESENCHYMAL STEM CELLS (MSC) ARE IN CLINICAL DEVELOPMENT FOR CARDIOVASCULAR, NEUROLOGIC, ORTHOPEDIC, AND O… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | INDIANAPOLIS, IN-07 | 2024 | $248,452 |
ASST_NON_R41GM140787_075 REDUCING A MAJOR COST BURDEN OF THERAPEUTIC CELL MANUFACTURING BY SELECTIVELYREMOVING TOXIC CULTURE BYPRODUCTS TO ALLOW RECYCLING OF MEDIA | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | INDIANAPOLIS, IN-07 | 2024 | $113,101 |
Top 7 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Funding Agencies
View All→Source: USAspending.gov · All Recipients · California